These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10557322)

  • 1. Increased levels of plasma lysosomal enzymes in patients with Lowe syndrome.
    Ungewickell AJ; Majerus PW
    Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13342-4. PubMed ID: 10557322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate.
    Zhang X; Hartz PA; Philip E; Racusen LC; Majerus PW
    J Biol Chem; 1998 Jan; 273(3):1574-82. PubMed ID: 9430698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase.
    Zhang X; Jefferson AB; Auethavekiat V; Majerus PW
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4853-6. PubMed ID: 7761412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete oculocerebrorenal phenotype of Lowe syndrome in a female patient with half reduction of inositol polyphosphate 5-phosphatase.
    Yamamoto K; Hasegawa Y; Ohata Y; Satomura K; Mizoguchi Y; Shimotsuji T; Yamamoto T
    CEN Case Rep; 2020 May; 9(2):95-100. PubMed ID: 31707643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oculocerebrorenal syndrome of Lowe: an update.
    Bökenkamp A; Ludwig M
    Pediatr Nephrol; 2016 Dec; 31(12):2201-2212. PubMed ID: 27011217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lowe syndrome, a deficiency of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus.
    Suchy SF; Olivos-Glander IM; Nussabaum RL
    Hum Mol Genet; 1995 Dec; 4(12):2245-50. PubMed ID: 8634694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased urinary excretion of the ectodomain form of megalin (A-megalin) in children with OCRL gene mutations.
    Suruda C; Tsuji S; Yamanouchi S; Kimata T; Huan NT; Kurosawa H; Hirayama Y; Tsukaguchi H; Saito A; Kaneko K
    Pediatr Nephrol; 2017 Apr; 32(4):621-625. PubMed ID: 27766457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oculocerebrorenal syndrome of Lowe: three mutations in the OCRL1 gene derived from three patients with different phenotypes.
    Kawano T; Indo Y; Nakazato H; Shimadzu M; Matsuda I
    Am J Med Genet; 1998 Jun; 77(5):348-55. PubMed ID: 9632163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells.
    Montjean R; Aoidi R; Desbois P; Rucci J; Trichet M; Salomon R; Rendu J; Fauré J; Lunardi J; Gacon G; Billuart P; Dorseuil O
    Hum Mol Genet; 2015 Feb; 24(4):994-1006. PubMed ID: 25305077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of OCRL increases ciliary PI(4,5)P
    Prosseda PP; Luo N; Wang B; Alvarado JA; Hu Y; Sun Y
    J Cell Sci; 2017 Oct; 130(20):3447-3454. PubMed ID: 28871046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a discrete behavioral phenotype in the oculocerebrorenal syndrome of Lowe.
    Kenworthy L; Charnas L
    Am J Med Genet; 1995 Nov; 59(3):283-90. PubMed ID: 8599350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.
    Jänne PA; Suchy SF; Bernard D; MacDonald M; Crawley J; Grinberg A; Wynshaw-Boris A; Westphal H; Nussbaum RL
    J Clin Invest; 1998 May; 101(10):2042-53. PubMed ID: 9593760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.
    Rendu J; Montjean R; Coutton C; Suri M; Chicanne G; Petiot A; Brocard J; Grunwald D; Pietri Rouxel F; Payrastre B; Lunardi J; Dorseuil O; Marty I; Fauré J
    Hum Mutat; 2017 Feb; 38(2):152-159. PubMed ID: 27790796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells.
    Barnes J; Salas F; Mokhtari R; Dolstra H; Pedrosa E; Lachman HM
    Mol Autism; 2018; 9():44. PubMed ID: 30147856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier assessment in families with lowe oculocerebrorenal syndrome: novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination.
    Röschinger W; Muntau AC; Rudolph G; Roscher AA; Kammerer S
    Mol Genet Metab; 2000 Mar; 69(3):213-22. PubMed ID: 10767176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosome positioning and mTOR activity in Lowe syndrome.
    Karabiyik C; Son SM; Rubinsztein DC
    EMBO Rep; 2021 Jul; 22(7):e53232. PubMed ID: 34047002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel OCRL1 gene mutations in six Chinese families with Lowe syndrome.
    Gao Y; Jiang F; Ou ZY
    World J Pediatr; 2016 Nov; 12(4):484-488. PubMed ID: 27059748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.
    De Matteis MA; Staiano L; Emma F; Devuyst O
    Nat Rev Nephrol; 2017 Aug; 13(8):455-470. PubMed ID: 28669993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular Pathology of Oculocerebrorenal Syndrome of Lowe: Novel Mutations and Genotype-Phenotype Analysis.
    Song E; Luo N; Alvarado JA; Lim M; Walnuss C; Neely D; Spandau D; Ghaffarieh A; Sun Y
    Sci Rep; 2017 May; 7(1):1442. PubMed ID: 28473699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and function of the Lowe syndrome protein OCRL1.
    Lowe M
    Traffic; 2005 Sep; 6(9):711-9. PubMed ID: 16101675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.